These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6980574)

  • 41. A clone specific monoclonal antibody which inhibits T cell-mediated cytolysis.
    Lancki DW; Lorber MI; Loken MR; Fitch FW
    Adv Exp Med Biol; 1982; 146():557-62. PubMed ID: 6808814
    [No Abstract]   [Full Text] [Related]  

  • 42. Clonal analysis of the involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions.
    Moretta A; Pantaleo G; Lopez-Botet M; Carrel S; Moretta L
    Behring Inst Mitt; 1985 Aug; (77):39-47. PubMed ID: 2417584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.
    Kruisbeek AM; Mond JJ; Fowlkes BJ; Carmen JA; Bridges S; Longo DL
    J Exp Med; 1985 May; 161(5):1029-47. PubMed ID: 3921649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of murine cytolytic-helper hybrid T cell clones.
    Havran WL; Fitch FW
    Nature; 1987 Jan 1-7; 325(6099):65-7. PubMed ID: 2948129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
    Boyce NW; Jönsson JI; Emmrich F; Eichmann K
    J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ; Krosnick JA; Rosenberg SA
    J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clonal analysis of the relationship between class II MHC-restricted cytolysis and lymphokine secretion in murine L3T4+ T cells.
    Gao XM; Liew FY; Bottomly K; Meager A; Tite JP
    Immunology; 1991 Feb; 72(2):256-60. PubMed ID: 1901831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal anti-Lyt-2 antibodies block the activation of cytolytic T lymphocyte precursors.
    Glasebrook AL; MacDonald HR
    J Immunol; 1983 Apr; 130(4):1552-5. PubMed ID: 6220055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of two anti-apo-cytochrome c-specific monoclonal antibodies on the function of apo-cytochrome c-specific murine T cell clones.
    Corradin G; Juillerat MA; Engers HD
    J Immunol; 1984 Dec; 133(6):2915-9. PubMed ID: 6208267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A specific serine proteinase is inducible in Lyt-2+,L3T4- and Lyt-2-,L3T4+ T cells in vitro but is mainly associated with Lyt-2+,L3T4- effector cells in vivo.
    Simon MM; Fruth U; Simon HG; Kramer MD
    Eur J Immunol; 1986 Dec; 16(12):1559-68. PubMed ID: 3102247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.
    Kelso A; Glasebrook AL
    J Immunol; 1984 Jun; 132(6):2924-31. PubMed ID: 6202766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of H-2I region-restricted cytolytic activity by an Lyt-2+ influenza virus-specific T lymphocyte clone.
    Morrison LA; Braciale VL; Braciale TJ
    J Immunol; 1985 Dec; 135(6):3691-6. PubMed ID: 2415581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
    van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
    J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytolytic activity of murine CD4+ T cell clones correlates with IFN-gamma production in mouse strains having a BALB/c background.
    McKisic MD; Lancki DW; Fitch FW
    J Immunol; 1993 May; 150(9):3793-805. PubMed ID: 8097225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal anti-Lyt-2.2 antibody blocks lectin-dependent cellular cytotoxicity of H-2-negative target cells.
    Hünig T
    J Exp Med; 1984 Feb; 159(2):551-8. PubMed ID: 6363597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.